Friday, February 01, 2008

Wyeth undercuts Teva on Protonix

Wyeth and Nycomed announced on Jan. 29 they are launching a generic version of heartburn medication Protonix. This hurts Teva's version, because the generic price will drop because of the additional generic competition.

See also

Teva to launch a generic version of Wyeth's Protonix

Mike Gladstone is AVP at Wyeth for Gastroenterology and Metabolic Diseases, overseeing Protonix (pantoprazole sodium).


Post a Comment

<< Home